Swiss Life Funds (LUX) Equity Global High Dividend CHF R Dis
Performance (in CHF)
Past performance is no indication of current or future performance. These performance data do not take account of the commissions and costs incurred on the issue and redemption of units.
Performance
| 1 month | 2.97% |
|---|---|
| Current year | 7.60% |
| 3 years p.a. | 5.60% |
| 5 years p.a. | 3.18% |
| 10 years p.a. | 4.33% |
| Since inception p.a. | n.a. |
Rolling performance in %
Key figures
| YTD | 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|---|
| Performance | 7.60% | 7.24% | 17.76% | 16.96% | 52.89% |
| Maximum profit on monthly basis | 4.39% | 4.39% | 6.20% | 9.12% | 10.81% |
| Maximum loss on monthly basis | -2.16% | -3.46% | -7.98% | -7.98% | -11.32% |
| Max drawdown | -5.40% | -5.40% | -14.13% | -14.81% | -32.10% |
| Volatility | 10.50% | 9.29% | 10.63% | 11.36% | 13.37% |
| Sharpe ratio | 1.69 | 0.57 | 0.25 | 0.12 | 0.28 |
| Maximum continuous profit in months | 2 | 2 | 3 | 3 | 4 |
| Maximum continuous loss in months | 1 | 1 | 2 | 4 | 4 |
| Positive months / profit duration in months | 4 | 9 | 22 | 34 | 66 |
| Negative months / loss duration in months | 1 | 4 | 15 | 27 | 55 |
Master data
| Fund name | Swiss Life Funds (LUX) Equity Global High Dividend CHF R Dis |
|---|---|
| Fund management company | Swiss Life Asset Managers Luxembourg |
| Fund domicile | Luxembourg |
| Inception date | 08 July 2008 |
| ISIN | LU0371451146 |
| Swiss security no. | 4323797 |
| Fund currency | CHF |
| Appropriation of income | distributing |
| Issuing commission | |
| Ongoing charges under PRIIP KID as at 01 January 2026 | 1.65% |
| End of financial year | 31 August |
| Paying agent | UBS Switzerland AG |
| Representative in Switzerland | Swiss Life Asset Management AG |
| Fund volume as at 31 March 2026 | 172.41 Mio. CHF |
| Net asset value (NAV) as at 20 May 2026 | 83.86 CHF |
Portfolio structure
Top holdings of fund volume (in %)
| Exxon Mobil Corp. | 3.15% | |
| Johnson & Johnson | 2.54% | |
| AbbVie, Inc. | 2.47% | |
| Procter & Gamble | 2.24% | |
| Cisco Systems, Inc. | 2.09% | |
| Novartis AG | 2.01% | |
| Verizon Communications Inc. | 1.71% | |
| Amgen Inc. | 1.50% | |
| Chevron Corp. | 1.49% | |
| Pfizer | 1.36% |